Indication
Bile Duct Neoplasms
3 clinical trials
7 products
5 drugs
Clinical trial
Phase II Study Evaluating the Efficacy of M9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic CholangiocarcinomaStatus: Recruiting, Estimated PCD: 2027-12-31
Drug
FOLFOXIRIDrug
mFOLFOX6Product
M9241Drug
GemcitabineProduct
DexamethasoneProduct
FloxuridineDrug
5-FUClinical trial
Feasibility Pilot of Hepatic Arterial Infusion Chemotherapy in a Rural Catchment Area, Using the Codman Vascular Catheter With the Synchromed II Pump, for Patients With Unresectable Colorectal Cancer Liver Metastases or Unresectable Intrahepatic CholangiocarcinomaStatus: Terminated, Estimated PCD: 2022-01-04
Clinical trial
Toxicity OF Fluoropyrimidines: A Comparative Study of the Cardiotoxicity of capEcitabine and tEysunoStatus: Completed, Estimated PCD: 2020-03-18
Product
TeysunoDrug
UTD1